(Q35011933)

English

Minimal disease assessment in the treatment of children and adolescents with intermediate-risk (Stage III/IV) B-cell non-Hodgkin lymphoma: a children's oncology group report

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Minimal disease assessment in the treatment of children and adolescents with intermediate-risk (Stage III/IV) B-cell non-Hodgkin lymphoma: a children's oncology group report (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

1 reference

based on heuristic

inferred from title

non-Hodgkin lymphoma

1 reference

based on heuristic

inferred from title

B-cell non-Hodgkin lymphoma

1 reference

based on heuristic

inferred from title

author name string

Bruce Shiramizu

1

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Stanton Goldman

2

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Ian Kusao

3

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Melissa Agsalda

4

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

James Lynch

5

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Lynette Smith

6

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Lauren Harrison

7

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Erin Morris

8

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Thomas G Gross

9

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Warren Sanger

10

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Sherrie Perkins

11

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Mitchell S Cairo

12

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

language of work or name

0 references

publication date

18 April 2011

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

British Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

153

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

758-763

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Combined analysis of minimal residual disease at two time points and its value for risk stratification in childhood B-lineage acute lymphoblastic leukemia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3103617

8 July 2018

Standardized MRD quantification in European ALL trials: proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3103617

8 July 2018

Screening for residual disease in pediatric burkitt lymphoma using consensus primer pools

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3103617

8 July 2018

Minimal disseminated disease in childhood T-cell lymphoblastic lymphoma: a report from the children's oncology group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3103617

8 July 2018

Specific cytogenetic abnormalities are associated with a significantly inferior outcome in children and adolescents with mature B-cell non-Hodgkin's lymphoma: results of the FAB/LMB 96 international study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3103617

8 July 2018

Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3103617

8 July 2018

Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3103617

8 July 2018

The human immunoglobulin VH repertoire

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3103617

8 July 2018

Excellent survival following two courses of COPAD chemotherapy in children and adolescents with resected localized B-cell non-Hodgkin's lymphoma: results of the FAB/LMB 96 international study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08681.X

21 January 2018

Prospective analysis of minimal bone marrow infiltration in pediatric Burkitt's lymphomas by long-distance polymerase chain reaction for t(8;14)(q24;q32).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08681.X

21 January 2018

Prognostic role of minimal residual disease in mature B-cell acute lymphoblastic leukemia of childhood.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08681.X

21 January 2018

The Société Française d'Oncologie Pédiatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08681.X

21 January 2018

Assessment of minimal residual disease in childhood non-hodgkin lymphoma by polymerase chain reaction using patient-specific primers.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08681.X

21 January 2018

Bone marrow minimal disseminated disease (MDD) and minimal residual disease (MRD) in childhood T-cell lymphoblastic lymphoma stage III, detected by flow cytometry (FC) and real-time quantitative polymerase chain reaction (RQ-PCR).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08681.X

21 January 2018

Association of cytogenetic abnormalities with detection of BCR-ABL fusion transcripts in children with T-lineage lymphoproliferative diseases (T-ALL and T-NHL)

1 reference

https://pubmed.ncbi.nlm.nih.gov/21496005

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

IGH and IGK gene rearrangements as PCR targets for pediatric Burkitt's lymphoma and mature B-ALL MRD analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21496005

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Classification, staging and end results of treatment of childhood non-Hodgkin's lymphomas: dissimilarities from lymphomas in adults

1 reference

https://pubmed.ncbi.nlm.nih.gov/21496005

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1365-2141.2011.08681.X

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35011933&oldid=1566715410"